A Cut Above: Cardiothoracic insights from EACTS

Join our hosts Can Gollmann-Tepeköylü and Miia L Lehtinen for their late-breaking trials highlights presented at the 38th EACTS Annual Meeting in Lisbon, including: (0:39 - 4:31) Long-term mortality after PCI or CABG in patients with diabetes and multivessel coronary artery disease: A SWEDEHEART study by Dr Emma C Hansson (4:32 - 8:33) Long-term (>10 years) results of transcatheter Mitral valve-in-valve implantation for degenerated surgical mitral bioprosthesis: Italian MItral VIV registry (MIVIV registry) by Dr Edoardo Zancanaro  (8:34 - 11:55) Personalized multimodal teleprehabilitation in elective cardiac surgery: results from the Digital Cardiac Counselling multicentered randomized Controlled Trial (ClinicalTrials.gov number, NCT04393636.) by Dr Bart Scheenstra   (11:55 - 16:15) 5-Year Results on Aortic Remodeling in the Dissected Aorta Repair Through Stent (DARTS) Implantation Trial by Dr Ryaan EL-Andari (16:16 - 19:49) Clinical impact of continuous postoperative pericardial flushing on bleeding-related complications after cardiac surgery by Dr Robert Klautz

Following the European Society of Cardiology’s (ESC) guidelines publication in collaboration with EACTS, Miia L Lehtinen and Can Gollmann-Tepeköylü host the esteemed Atrial Fibrillation experts, Manuel Castella and Niv Ad. In this month’s episode, our guests explore the nuances of how a surgical approach might be used to treat Atrial Fibrillation and why cardiac surgeons are increasingly interested in this complex electrophysiological condition. In light of the developing accepted practices, listeners can expect comparisons between the Maze procedure and non-surgical approaches, as well as an exploration of the endpoints used to determine patient outcomes.

This month’s episode is hosted by Miia L Lehtinen and Can Gollmann-Tepeköylü, who are joined by Wouter Oosterlinck, exploring his experience and expertise in the field of robotic cardiac surgery. Although already popular amongst thoracic surgeons, Wouter discusses the creation of his fast growing minimally invasive programme, which has been influential in this emerging field. Listen in for insight into the ever-developing applications of robotic cardiac surgery as well as the challenges being faced, such as nuanced medical device regulations.

In this Episode, our hosts Can Gollmann-Tepeköylü and Miia L Lehtinen speak with Karl-Henrik Grinnemo on the provocative subject of scientific misconduct. Listeners can expect to hear a firsthand experience of his notorious high-profile case discrediting the use of dangerous artificial tracheae. Karl describes his team's journey from reporting poor patient outcomes in 2013, to being wrongfully accused of misconduct, and to finally being exonerated in 2016. Tune in to hear this unique story of courage, controversy, and vindication.